Benzgalantamine, sold under the brand name Zunveyl, is a medication used for the treatment of mild to moderate dementia of the Alzheimer's type.

[1] The most common side effects include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite.

[1] Benzgalantamine was approved for medical use in the United States in July 2024.

[1][2][3] Benzgalantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults.

[1][2] The most common side effects include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite.